Inder Singh is the founder and CEO of Kinsa, a public health company using digital technology to curb the spread of infectious illness. Aggregating population health insights from its network of smart thermometers, Kinsa has created an early warning system shown to predict the flu 12-20 weeks in advance, and shown to be an early indicator of COVID-19 outbreaks, predicting hotspots nearly 3 weeks before hospitalizations and deaths. Insights from Kinsa’s early warning system have been used by nearly every major news outlet, including the New York Times, CNBC, MSNBC, FOX News and CNN, among others.
Prior to founding Kinsa, Inder served as the Executive Vice President of the Clinton Health Access Initiative. In this capacity, he worked with or advised the US’ President’s Malaria Initiative (PMI) and PEPFAR programs, the UK’s DFID, the Gates Foundation, and WHO’s UNITAID program. He brokered a series of agreements between 70 developing countries and 20 pharmaceutical companies that lowered the price of medicines for AIDS, malaria and TB, enabling millions of children to access treatment and resulted in more than $1 billion in cost savings.
Inder started his career as a software engineer and consultant. Inder holds 3 graduate degrees from Harvard and MIT and is a proud University of Michigan alum.
